Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

NCT01126138 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Invasive Ductal, Breast

Interventions

DRUG: Vinorelbine plus Capecitabine for 6 cycles, followed by Capecitabine
DRUG: Docetaxel plus Capecitabine for 6 cycles, followed by Capecitabine

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]